• Catalog Number:

  E21-A027-1

• Amount:

  50ug

• Form of Antibody:

  stability：24 months from manufacturing at <-20 °C; 1 month, 2 to 8 °C under sterile conditions.Pair recommendations: Capture antibody Detection antibody ED50 Cat# E21-A027-1, 2019-nCoV NP Antibody Cat# E21-A028-1, Recombinant anti-2019-nCoV NP ScFv 149.6ng/ml Cat# E21-A027-1, 2019-nCoV NP Antibody Cat# E21-A029-1, Anti-2019-nCoV NP ScFv-Fc (Single-chain variable fragment ) 72.6ng/ml Cat# E21-A028-1, Recombinant anti-2019-nCoV NP ScFv Cat# E21-A027-1, 2019-nCoV NP Antibody 19.6ng/ml Cat# E21-A029-1, Anti-2019-nCoV NP ScFv-Fc (Single-chain variable fragment ) Cat# E21-A027-1, 2019-nCoV NP Antibody 23.0ng/ml Please note that pair recommendations are based on results obtained by our laboratory. Equally good results may be obtained using other pairs and therefore these recommendations are only for reference.

• Source:

   Cultrued in vitro under conditions free from animal derived components.

• Specificity Sensitivity:

   Antibody recognizes 2019-nCoV Nucleocapsid Protein

Immobilized 2019-nCoV Nucleocapsid protein (CAT#E21-RA31-1) at 5.0ug/ml (100ul/well) can bind 2019-nCoV NP Antibody (CAT# E21-A027-1), the EC50 is less than 13.78ng/ml.

Stability is confirmed by binding ability with 2019-nCoV Nucleocapsid Protein (Cat#E21-RA31-1). The result showed that product bioactivity had no significant differences among these samples stored at 4℃ for 0, 3 , 7，14 days, respectively.